ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,901.46
-0.27%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Processa Pharmaceuticals Inc (PCSA)

  7. Processa Pharmaceuticals Inc (PCSA) Noticias

PCSA

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PCSA
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
06/05/202407:00GlobeNewswire Inc.Processa Pharmaceuticals to Participate in the EF Hutton Annual Global ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/04/202407:00GlobeNewswire Inc.Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical ResearchNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/04/202407:00GlobeNewswire Inc.Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
28/03/202407:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
25/03/202407:15GlobeNewswire Inc.Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingNASDAQ:PCSAProcessa Pharmaceuticals Inc
21/02/202416:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
21/02/202407:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
14/02/202412:00GlobeNewswire Inc.Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
06/02/202407:30GlobeNewswire Inc.Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:PCSAProcessa Pharmaceuticals Inc
01/02/202417:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
01/02/202415:22GlobeNewswire Inc.Processa Pharmaceuticals Announces Closing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
29/01/202415:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
28/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PCSAProcessa Pharmaceuticals Inc
26/01/202408:04GlobeNewswire Inc.Processa Pharmaceuticals Announces Pricing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
25/01/202407:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 DosesNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/01/202406:45GlobeNewswire Inc.Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
18/01/202406:45GlobeNewswire Inc.Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock SplitNASDAQ:PCSAProcessa Pharmaceuticals Inc
02/01/202416:06GlobeNewswire Inc.Processa Pharmaceuticals to Present at the Biotech Showcase 2024NASDAQ:PCSAProcessa Pharmaceuticals Inc
29/12/202307:55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PCSAProcessa Pharmaceuticals Inc
19/12/202308:00GlobeNewswire Inc.Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/12/202308:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/11/202307:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Oncology Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
29/11/202307:15GlobeNewswire Inc.Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and OutlookNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/11/202312:40GlobeNewswire Inc.Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil ThompsonNASDAQ:PCSAProcessa Pharmaceuticals Inc
09/11/202307:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 AmericasNASDAQ:PCSAProcessa Pharmaceuticals Inc
01/11/202307:15GlobeNewswire Inc.Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion LeadersNASDAQ:PCSAProcessa Pharmaceuticals Inc
13/10/202312:08GlobeNewswire Inc.Processa Pharmaceuticals to Present at the ThinkEquity ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202309:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PCSAProcessa Pharmaceuticals Inc
05/10/202309:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA

Su Consulta Reciente

BIT
UV8DAL
UniCredit Bank
ASX
EQU
NASDAQ
AAYZHXX
Hsbc Bank Usa Na Capped ...
AQSE
RCN.GB
Redcentric
EU
B457S
B457S
LSE
0DQP
Marie Brizard Wine And S...
BTRX
EWTUSD
LSE
FR51
Newday Fmi 26 S
USOTC
CAIXY
Caixabank (PK)
COIN
UBCETH
UBCoin
AMEX
NWLG
Nuveen Winslow Large Cap...
BIT
HYDE
Invesco Hydrogen Economy...
NASDAQ
CRGID
LSE
XZMD
Xmsci Usa Esg1d
NASDAQ
JTFXX
Jpmorgan Tax Free Money Market F
COIN
OYSUSD
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados